AbbVie (Cencora / Lash Group)
Data Breach Class Action Lawsuit
May 22, 2024 -- Attention: victims of the AbbVie data breach.
Abington Cole + Ellery is investigating the data breach recently announced by AbbVie.
AbbVie data breach summary:
Unfortunately, at this time very little information is publicly available about the recently announced AbbVie data breach. A filing with the Attorney General of Texas on May 22, 2024, indicates that there was a data security breach affecting medical information of more than 54,300 Texans. According to information filed with the Attorney General of Texas, notice of the data security breach is being sent to affected consumers in Texas.
This data breach appears to be part of the recently announced Cencora / Lash Group data breach. It is not clear if notices regarding this breach will come from Cencora / Lash Group, or from AbbVie, or from both.
It is unclear if AbbVie is offering credit monitoring and/or identity theft protection services to affected individuals at this time. Data Breach notices being sent to affected individuals by Cencora / Lash Group include an offer for 24 months of free credit monitoring and/or identity theft protection services.
Tens of thousands of individuals were affected by the AbbVie data breach.
Breached data may include, but is not necessarily limited to: names, dates of birth, addresses, and medical data.
About AbbVie:
AbbVie is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines. Established in 2013, after separating from Abbott Laboratories, AbbVie has a strong commitment to addressing complex and serious health conditions. The company's portfolio includes treatments in several therapeutic areas, including immunology, oncology, neuroscience, eye care, virology, and women's health.
The company operates in over 175 countries, employing a diverse workforce dedicated to improving patient outcomes. AbbVie's research and development efforts are driven by a comprehensive approach that combines advanced science with a deep understanding of disease biology. This approach enables the company to develop therapies that have a significant impact on patients' lives. AbbVie collaborates with a range of partners, including academic institutions, industry peers, and patient organizations, to advance its scientific goals.
In addition to its focus on innovation, AbbVie is committed to corporate responsibility and sustainability. The company engages in various initiatives aimed at improving global health, supporting communities, and minimizing its environmental footprint. Through its philanthropic efforts and partnerships, AbbVie seeks to make a positive impact on society while maintaining a focus on ethical business practices and compliance.
The AbbVie Website may have additional information about or provide periodic updates regarding the data breach.
For more information about steps you can take to possibly reduce the chances harm arising from a data breach, please review the following article: What are some steps you can take if you've been the victim of a data breach?
This website is not associated with nor authorized by AbbVie or any affiliated companies.